#SupremeCourt revives #Mississippi evangelist’s challenge to protest ordinance #msnews #LAFirstNews www.louisianafirstnews.com/news/hill-po...
1
1
0
0
Hashtag
#MSNEWS
Advertisement · 728 × 90
News - Supplement linked to 42% lower MS risk 💊
New research has found that a higher intake of vitamin D from food or supplements was linked to a lower risk of developing MS in a large long-term study. 🌤️
Find out more below
ms-uk.org/news/supplem...
#MS #MSNews #MSUpdate #MSResearch #Supplements
0
0
0
0
IN HER MEMORY
Block the new account and ask all to do the same.
They are Trump's private paramilitary working to disrupt 2026 elections
@icegov.bsky.social
#Epstein
#Justice
#Dansk
#NATO
#Democracy
#Vote
#ICE
#Minnesota
#SCOTUS
#Terrorists
#GREENLAND
#Vote2026
#Resist
#MSNEWS
#Media
1
1
0
0
—>> #MSNOW ⦁ Highlights ⦁ #MSNEWS <<—
MS NOW Highlights - Jan. 7
⏱️41:47 #Trump #Politics #Immigration
#Pol #Politics #GeoPolitics #WorldNews #News
#AusPol #CdnPoli #EUpol #NZpol #UKpol #USpol
youtu.be/cYoGMYTzKTU
0
0
0
0
#SupremeCourt will hear appeal of Black death row inmate over racial bias in #Mississippi jury makeup #msnews #msgov #LAFirstNews www.louisianafirstnews.com/news/mississ...
0
0
0
0
#MSNBC is now #MSNews. They do have some good news shows and coverage. It’s pretty good, even though most of our news is owned by big corporations, and they want their corporate tax cuts, even though conservatives like to say the media is liberal, even though that is bullshit.
3
0
1
0
🧬 MS News – Epstein-Barr virus antibodies don’t predict MS progression
Click here to find out more - ms-uk.org/news/epstein...
#MSUK #MSNews #MultipleSclerosis #MSResearch #EpsteinBarrVirus #MSCommunity
3
1
0
0
Illustration of a winding path with colorful markers and a speech bubble stating, "New data offer a plausible timeline for how MS develops years before symptoms." "MultipleSclerosisNewsToday.com" is noted as source at bottom.
Recent findings could be a “game changer” for how we understand and manage MS. Explore how they might open new avenues to treat the disease at very early stages or even prevent it altogether: https://bit.ly/4oeVzk0
#MS #MultipleSclerosis #MSTreatment #MSNews #MSLife #LivingWithMS #Bionews
1
0
0
0
Illustration of a person with a headache, surrounded by swirling symbols. The text reads, "Are headaches worse for MSers? A new study says yes." "MultipleSclerosisNewsToday.com" is noted as source at bottom.
Not only are MS patients more than twice as likely to experience headaches, but the headaches themselves tend to be more intense and last longer.
Review the results out of Greece here: https://bit.ly/4qovKPJ
#MS #MultipleSclerosis #MSSymptoms #LivingWithMS #MSLife #MSNews #Bionews
0
0
0
0
The Latest News: Two compounds show potential for myelin repair in MS, promising results in animal and cell models. Swipe to read more.
Megaphone and speech bubbles on a blue background. Text says, "One protein that has been identified as a potential target for promoting myelin repair in MS is the estrogen receptor beta (ER-beta), which is produced throughout the body, enabling cells to respond to certain hormones."
Megaphone and speech bubbles on blue background with text: "Data suggest that activating ER-beta in the brain can promote the production of new myelin." Swipe to read more.
Megaphone and speech bubbles with text, "In experiments done using cell models, K102 and K110 were shown to promote the growth and maturation of oligodendrocytes, the cells chiefly responsible for making and repairing myelin in the brain and spinal cord."
A recent study has unveiled two experimental compounds that show remyelination potential. See how this progress could redefine what we expect from future therapies: https://bit.ly/4hjg4ZT
#MS #MultipleSclerosis #MSResearch #MSTreatment #EndMS #MSNews #MSNewsToday #Bionews
0
0
0
0
🐬 Proposed rollbacks to the Marine Mammal Protection Act could harm Mississippi’s dolphins and coastal economy.
@oceana.bsky.social warns: weakening protections risks irreversible damage to Gulf ecosystems.
#MarineMammals #MarineConservation #GulfCoast #MSnews #NOAA #MMPA
2
2
0
0
A potential myelin-repairing medication is on the horizon. Some good news for us with MS.
#MultipleSclerosis #disability #MSNews #Phase2 #ClinicalTrials
multiplesclerosisnewstoday.com/news-posts/2...
2
1
0
0
Illustration of a thoughtful woman surrounded by puzzle pieces, with text asking about a breakthrough in myelin repair for MS. "MultipleSclerosisNewsToday.com" is noted as source at bottom.
ICYMI: New research could “help deliver on the promise of regenerative therapies that MS patients so urgently need.” See how: https://bit.ly/3IJPDzK
#MS #MultipleSclerosis #MSResearch #MSTreatment #MSCommunity #MyelinRepair #Remyelination #MSNews #Bionews
0
0
0
0
Research from ECTRIMS 2025 suggests the MIND diet may reduce physical disability and fatigue in MS. A graphic of assorted food is positioned below the text. "MultipleSclerosisNewsToday.com." is noted as source at bottom.
How might a diet focusing on brain health help in MS? Findings out of #ECTRIMS2025 offer some clues: https://bit.ly/4nFa3cF
#MS #MultipleSclerosis #MSResearch #MSDiet #MSCommunity #LivingWithMS #MSNews #Bionews
1
0
0
0
An infographic describes what the updated McDonald criteria mean for MS diagnosis. "MultipleSclerosisNewsToday.com" is noted as source at bottom.
What do the new McDonald criteria revisions mean for the future of MS diagnosis? Review the implications, presented at #ECTRIMS2025: https://bit.ly/42bF6nA
#MS #MultipleSclerosis #MSResearch #MSDiagnosis #MSCommunity #MSNews #Bionews
0
0
0
0
A graphic features hands assembling puzzle pieces. The text above reads, "Tune in to Multiple Sclerosis News Today’s live and virtual coverage of ECTRIMS 2025." "MultipleSclerosisNewsToday.com" is noted as source at bottom.
The world’s largest meeting on MS has begun, and we’re bringing you all you need to know! Stay tuned right here for our coverage of all the latest news. And learn more about the 41st congress here: https://bit.ly/3WbOX9j
#ECTRIMS2025 #MS #MSResearch #MSCommunity #MSNews #Bionews
1
0
0
0
Two researchers discuss a medication while another person stands nearby. The text above reads as follows: "FDA pushes back tolebrutinib decision, now expected Dec. 28." "MultipleSclerosisNewsToday.com" is noted as source at bottom.
See why the FDA says it needs extra time to make a decision on the approval of the BTK inhibitor: https://bit.ly/47QDt2i
#MS #MultipleSclerosis #MSTreatment #MSResearch #MSCommunity #LivingWithMS #EndMS #MSNews #Bionews
0
0
0
0
A doctor reviews brain scans on a screen. The text above reads, "Can paramagnetic rim lesions help diagnose MS early?" "MultipleSclerosisNewsToday.com." is noted as source at bottom.
See why researchers say paramagnetic rim lesions may be most useful as a biomarker during initial diagnostic workups: https://bit.ly/3IxuEQB
#MS #MultipleSclerosis #MSDiagnosis #MSResearch #MSCommunity #MSAwareness #MSNews #Bionews
0
0
0
0
A researcher examines samples under a microscope in a lab. The text above reads, "A first-of-its-kind blood test is one step closer to being 'the new standard of care' in MS." "MultipleSclerosisNewsToday.com" is noted as source at bottom.
Measuring 18 proteins reflecting biological processes in MS, the test just received major commercialization funding. Explore its potential to help guide care decisions for MSers: https://bit.ly/46gbVkg
#MS #MSResearch #MSNews #LivingWithMS #MSCommunity #Bionews
0
0
0
0
Illustration of a woman injecting herself with medication. The above text reads, "A Phase 3 trial has begun testing an at-home injectable version of Briumvi." "MultipleSclerosisNewsToday.com" is noted as source at bottom.
If results are positive, the study could support the new formulation’s approval as early as 2028. It'd be the only anti-CD20 therapy offered as an intravenous infusion and a self-administered subcutaneous one. Learn more: https://bit.ly/42yObqz
#MS #MSTreatment #MSResearch #MSNews #ClinicalTrial
1
0
0
0
Illustration of two people tugging a rope tied around a person in the middle. The text above states that nearly 4 out of 5 neurologists prescribing MS therapies receive payments from related pharmaceutical companies. "MultipleSclerosisNewsToday.com" is noted as source at bottom.
The findings show neurologists who receive payments from a company are significantly more likely to prescribe that company’s drugs to their patients. Review the findings in detail: https://bit.ly/4piTsw7
#MS #MSCommunity #MSAwareness #PharmaInfluence #Transparency #HealthcareEthics #MSNews #Bionews
0
0
0
0
A graphic of a healthcare worker holding a mask to a patient's face. The following text appears above: "Glatiramer acetate products for RRMS may cause severe anaphylactic reactions, warns Health Canada." Key symptoms to look out for include difficulty breathing, swelling, dizziness, and rapid blood pressure drop. "MultipleSclerosisNewsToday.com" is noted as source at bottom.
The warning comes after 14 cases of anaphylaxis were tied to use of glatiramer acetate. See the specifics: https://bit.ly/4mVjWSR
#MS #MultipleSclerosis #MSTreatment #MSResearch #MSCommunity #MSNews #Bionews
0
1
0
0
Illustration of a thoughtful woman surrounded by puzzle pieces, with text asking about a breakthrough in myelin repair for MS. "MultipleSclerosisNewsToday.com" is noted as source at bottom.
New research could “help deliver on the promise of regenerative therapies that MS patients so urgently need.” See how: https://bit.ly/3JNmOmn
#MS #MultipleSclerosis #MSResearch #MSTreatment #MSCommunity #MyelinRepair #Remyelination #MSNews #Bionews
0
0
0
0
MS News Alert: UAE first to approve tolebrutinib for treating adults with nonrelapsing SPMS. "MultipleSclerosisNewsToday.com" is noted as source at bottom.
The oral BTK inhibitor is the first approved therapy to directly address the chronic inflammation that contributes to disability progression independent of relapses. See how it works: https://bit.ly/4lSD9Dw
#MS #MultipleSclerosis #MSNews #MSTreatment #MSCommunity #TherapyApproval #Bionews
0
0
0
0
A pharmacist stands next to a large pill bottle, highlighting that a generic version of Ampyra is available in the U.S. for under $40. "MultipleSclerosisNewsToday.com" is noted as source at bottom.
Dalfampridine was chosen as a priority product because of its high list price and “significant patient need.” Learn about other low-cost versions of high-priced drugs here: https://bit.ly/4g3Ov6m
#MS #MultipleSclerosis #MSTreatment #AffordableMeds #MSCommunity #MSNews #Bionews
0
0
0
0
Four people discuss data at a conference table, with a chart in the background. The text above reads, "A new tool called the MS Clinical and Imaging Data Resource aims to accelerate the search for effective treatments for progressive disease forms." "MultipleSclerosisNewsToday.com" is noted as source at bottom.
The resource is one of the largest collections of MS data ever assembled. See how its large pool of anonymized data will help researchers worldwide better understand MS progression: https://bit.ly/4mzYiTY
#MS #MSResearch #MSTreatment #MSNews #ProgressiveMS #PPMS #EndMS #Bionews
0
0
0
0
A young girl in a hospital waiting room holding a flower painting, with text above reading, "Clinical trial findings suggest that early high-efficacy treatment may be preferable in pediatric MS." "MultipleSclerosisNewsToday.com" is noted as source at bottom.
In one study, nearly half of patients on Copaxone and one-third of those on Avonex switched to a high-efficacy treatment because of partial disease control. Explore the findings in full: https://bit.ly/4mur9co
#MS #PediatricMS #MSResearch #MSTreatment #MSCommunity #MSNews #Bionews
0
0
0
0
A graphic illustration of a person on a scale with a healthcare provider standing beside, indicating concern. The following text appears above: "A higher BMI, especially during adolescence and early adulthood, increases odds of developing MS by about 40%, new findings show." "MultipleSclerosisNewsToday.com" is noted as source at bottom.
The research suggests that early-life weight management could serve as a preventive strategy against MS. Take a look at how here: https://bit.ly/3HV3B1l
#MS #MSResearch #MSRiskFactors #MSNews #MSCommunity #MSAwareness #Bionews
0
0
0
0
A meta-analysis offers preliminary evidence of the benefits of a keto diet for improved neurological function and fatigue management. Take a look at the findings: https://bit.ly/3JuU1mn
#MS #MultipleSclerosis #MSAndDiet #MSResearch #MSCommunity #MSNews #KetoDiet #Bionews
0
0
0
0
New research has identified HLA-A∗03:01 as a predictive and genetic treatment biomarker for MS. See what the finding means for personalized disease treatment: https://bit.ly/4mCaP9O
#MS #MSTreatment #MSResearch #MSNews #MSCommunity #Bionews
2
1
0
0